2-iminoimidazole derivatives (2)

Details 2-iminoimidazole derivatives (2) 2-iminoimidazole derivatives (2)

2007-12-04

2007-12-04

Saeed, Kamal A. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S392000, C548S311100, C548S326500, C548S331100

Reexamination Certificate

active

10475118

ABSTRACT:
A 2-iminoimidazole derivative represented by the formula:{wherein R1, R2and R3represent hydrogen, optionally substituted C1-6alkyl, etc.; R6represents hydrogen, C1-6alkyl, C1-6alkyloxycarbonyl, etc.; Y1represents a single bond, —CH2—, etc.; Y2represents a single bond, —CO—, etc.; and Ar represents hydrogen, a group represented by the formula:[wherein R10–R14represent hydrogen, C1-6alkyl, hydroxyl, C1-6alkoxy, etc., and R11and R12or R12and R13may bond together to form a 5- to 8-membered heterocycle], etc.}or salt thereof.

REFERENCES:
patent: 3717648 (1973-02-01), Diana
patent: 3773788 (1973-11-01), Vis
patent: 3859302 (1975-01-01), Dixon
patent: 3887577 (1975-06-01), Dixon
patent: 3904395 (1975-09-01), Eilrich et al.
patent: 3920688 (1975-11-01), Elrich et al.
patent: 3989709 (1976-11-01), White et al.
patent: 4004016 (1977-01-01), Yale et al.
patent: 4075342 (1978-02-01), Sale et al.
patent: 4118504 (1978-10-01), Giraldi et al.
patent: 4126613 (1978-11-01), Grisar et al.
patent: 4521793 (1985-06-01), Kabashima et al.
patent: 5143912 (1992-09-01), Burner et al.
patent: 5258387 (1993-11-01), Burner et al.
patent: 5362738 (1994-11-01), Burner et al.
patent: 5677322 (1997-10-01), Yasumura et al.
patent: 5935952 (1999-08-01), Todo et al.
patent: 5977134 (1999-11-01), Ciccarone et al.
patent: 6046211 (2000-04-01), Hansen, Jr. et al.
patent: 6051718 (2000-04-01), Freyne et al.
patent: 6077320 (2000-06-01), Andrean et al.
patent: 6087380 (2000-07-01), Hauel et al.
patent: 6114532 (2000-09-01), Ries et al.
patent: 6187799 (2001-02-01), Wood et al.
patent: 6194447 (2001-02-01), Jensen et al.
patent: 6376530 (2002-04-01), Claiborne et al.
patent: 2004/0004204 (2004-01-01), Wang
patent: 2004/0242627 (2004-12-01), Suzuki et al.
patent: 2004/0254376 (2004-12-01), Suzuki et al.
patent: 2005/0245592 (2005-11-01), Suzuki et al.
patent: 2006/0058370 (2006-03-01), Shimomura et al.
patent: 2003825 (1970-12-01), None
patent: 2154525 (1972-06-01), None
patent: 2551868 (1976-08-01), None
patent: 364204 (1989-10-01), None
patent: 638075 (1994-02-01), None
patent: 842161 (1996-07-01), None
patent: 934280 (1997-09-01), None
patent: 847749 (1997-11-01), None
patent: 1091942 (1999-07-01), None
patent: 1176141 (2000-03-01), None
patent: 1178802 (2000-11-01), None
patent: 8129 (1997-08-01), None
patent: 1295478 (1972-11-01), None
patent: 1344663 (1974-01-01), None
patent: 48-42875 (1973-12-01), None
patent: S51-22720 (1976-02-01), None
patent: S51-125071 (1976-11-01), None
patent: 53-71063 (1976-12-01), None
patent: 62-22760 (1985-07-01), None
patent: 4-244083 (1990-08-01), None
patent: 3-50555 (1991-03-01), None
patent: 4-504709 (1992-08-01), None
patent: H07-32103 (1995-02-01), None
patent: H08-225753 (1996-09-01), None
patent: 9-40643 (1997-02-01), None
patent: 10-167965 (1998-06-01), None
patent: 10-509150 (1998-09-01), None
patent: 11-509191 (1999-08-01), None
patent: 12-503678 (2000-03-01), None
patent: 2002-155060 (2002-05-01), None
patent: 2003-040949 (2003-02-01), None
patent: WO83/02920 (1983-09-01), None
patent: WO96/05192 (1996-02-01), None
patent: WO98/00408 (1998-01-01), None
patent: WO98/37075 (1998-08-01), None
patent: WO99/26943 (1999-06-01), None
patent: WO99/40072 (1999-08-01), None
patent: WO00/01676 (2000-01-01), None
patent: WO00/53582 (2000-09-01), None
patent: WO 00/67755 (2000-11-01), None
patent: WO 2004/78721 (2004-09-01), None
Ahn, et al., Structure-Activity relationships of pyrroloquinazolines as thrombin receptor antagonists., Bio. & Med. Chem. Let., vol. 9, pp. 2073-2078, especially p. 2073 (1999).
Bernatowicz et al., Development of potent thrombin receptor antagonist peptides, J. Med. Chem., 1996, vol. 39, pp. 4879-4887, especially p. 4879.
Ahn et al., Development of Proteinase-Activated Receptor 1 Antagonists as Therapeutic Agents for Thrombosis, Restensosi and Inflammatory Diseases, Current Pharmaceutical Design, 2003, 9 pp. 2349-2365, especially p. 2355, compound 18.
Ahn et al., Development of Proteinase-Activated Receptor 1 Antagonists as Therapeutic Agents for Thrombosis, Restensosi and Inflammatory Diseases, Current Pharmaceutical Design, 2003, 9 pp. 2349-2365, especially p. 2355, compound 18.
Ahn, et al., “Structure-Activity Relationships of Pyrroloquinzaolines as Thrombin Receptor Antagonists”,Bioorganic&Medicinal Chemistry Letters, 9; 2073-2078, 1999.
Bernatowicz, et al., “Development of Potent Thrombin Receptor Antagonist Peptides”,J. Med Chem. 39: 4879-4887, 1996.
Cohen, et al., “Enantiospecific Syntheses of Leukotrienes C4, D4, and E4and [14,15-3H2] Leukotriene E4Dimethyl Ester”,J. Am. Chem. Soc. 105: 3661-3672, 1983.
Compernolle, et al., “Synthesis and Preliminaryin vitroMetabolic Studies on N,N-Dimethyl-N′-2-Imidazolyl-N-Benzyl-1,2-Ethanediamine, an Analog of the Carcinogenic Antihistamine Methapyrilene”,J. Heterocyclic Chem, 19: 1403-1408, 1982.
Hoekstra, et al., “Thrombin Receptor (Par-1) Antagonists, Heterocycle-Based Peptidomimetics of the Sfllr Agonist Motif”,Bioorganic&Medicinal Chemistry Letters, 8: 1649-1654, 1998.
Hung, et al., “Cloned Platelet Thrombin Receptor is Necessary for Thrombin-Induced Platelet Activation”,J. Clin. Invest.,89: 1350-1353, 1992.
Hung, et al., “Thrombin-Induced Events in Non-Platelet Cells are Mediated by the Unique Proteolytic Mechanism Established for the Cloned Platelet Thrombin Receptor”,The Journal of Cell Biology, 116: 827-832, 1992.
Janusz, et al., “New Cyclooxygenase—2/5-Lipoxygenase Inhibitors. 1. 7-tert-Butyl-2,3-Dihydro-3,3-Dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents: Discovery and Variation of the 5-Keto Substituent”,J. Med. Chem. 41: 1112-1123, 1998.
Lipinski, et al., “Bioisosteric Prototype Design of Biaryl Imidazolyl and Triazolyl Competitive Histamine H2-Receptor Antagonists”,J. Med. Chem. 29: 2154-2163, 1986.
Liu, et al., “The Mechanism of Titanium Complex-Catalyzed Reduction of Aryl Halides by Sodium Borohydride is Strongly Solvent Dependent”,J. Org. Chem. 59: 940-942, 1994.
Mancuso, et al., “Activated Dimethyl Sulfoxide: Useful Reagents for Synthesis”,Reviews, 165-185, 1981.
McComsey, et al., “Macrocyclic Hexapeptide Analogues of the Thrombin Receptor (Par-1) Activation Motif Sfllrn”,Bioorganic&Medicinal Chemistry Letters9: 255-260, 1999.
Ngaiza, et al., “A 14 Amino Acid Peptide Derived from the Amino Terminus of the Cleaved Thrombin Receptor Elevates Intracellular Calcium and Stimulates Prostacyclin Production in Human Endothelial Cells”,Biochemical and Biophysical Research Communications, 179(3): 1656-1661, 1991.
Sarembock, et al., “Effectiveness of Recombinant Desulphatohirudin in Reducing Restenosis After Balloon Angioplasty of Atherosclerotic Femoral Arteries in Rabbits”,Circulation, 84: 232-243, 1991.
Sato, et al., “Organic Solvent-and Halide-Free Oxidation of Alcohols with Aqueous Hydrogen Peroxide”,J. Am. Chem. Soc., 119: 12386-12387, 1997.
Tawada, et al., “Studies on Antidiabetic Agents. IX.. A New Aldose Reductase Inhibitor, AD-5467, and Related 1,4-Benzoxazine and 1,4-Benzothiazine Derivatives: Synthesis and Biological Activity”,Chem. Pharm, Bull. 38(5): 1238-1245, 1990.
Vassallo, et al., “Structure-Function Relationships in the Activation of Platelet Thrombin Receptors by Receptor-Derived Peptides”,The Journal of Biological Chemistry, 267(9): 6081-6085, 1992.
Vu, et al., “Domains Specifying Thrombin-Receptor Interaction”,Nature, 353: 674-677, 1991.
Vu, et al., “Molecular Cloning of a Functional Thrombin Receptor Reveals a Novel Proteolytic Mechanism of Receptor Activation”,Cell, 64: 1057-1068, 1991.
Zhao, et al., “A Novel Chromium Trioxide Catalyzed Oxidation of Primary Alcohols to the Carboxylic Acids”,Tetrahedron Letters, 39: 5323-5326, 1998.
Alfaia, et al., “Quaternization Reaction of Heterocycli

Affiliated with

Also associated with

Rating

2-iminoimidazole derivatives (2) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-iminoimidazole derivatives (2), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-iminoimidazole derivatives (2) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3892169